Efficacy, Safety, and Tolerability of Gepotidacin (GSK2140944) in the Treatment of Patients with Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections

Gepotidacin is a novel, first-in-class, triazaacenaphthylene antibacterial agent which has in vitro activity against causative pathogens of acute bacterial skin and skin structure infections (ABSSSIs). This phase 2, randomized, 2-part, multicenter, dose-ranging, response-adaptive study with optional...

Full description

Saved in:
Bibliographic Details
Published in:Antimicrob Agents Chemother
Main Authors: O'Riordan, William, Tiffany, Courtney, Scangarella-Oman, Nicole, Perry, Caroline, Hossain, Mohammad, Ashton, Teri, Dumont, Etienne
Format: Artigo
Language:Inglês
Published: American Society for Microbiology 2017
Subjects:
Clinical Therapeutics
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5444153/
https://ncbi.nlm.nih.gov/pubmed/28373199
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02095-16
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items